1. Home
  2. NEXA vs OCUL Comparison

NEXA vs OCUL Comparison

Compare NEXA & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$15.17

Market Cap

1.9B

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.81

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
OCUL
Founded
1956
2006
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
NEXA
OCUL
Price
$15.17
$8.81
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$10.40
$23.56
AVG Volume (30 Days)
1.2M
2.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
0.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,990,000.00
Revenue This Year
$8.69
$7.93
Revenue Next Year
N/A
$96.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.48
52 Week Low
$4.62
$6.23
52 Week High
$16.89
$16.44

Technical Indicators

Market Signals
Indicator
NEXA
OCUL
Relative Strength Index (RSI) 53.56 49.71
Support Level $13.68 $8.36
Resistance Level $16.82 $9.93
Average True Range (ATR) 0.89 0.44
MACD 0.04 0.01
Stochastic Oscillator 59.04 62.67

Price Performance

Historical Comparison
NEXA
OCUL

About NEXA Nexa Resources S.A.

Nexa Resources SA operate large-scale, mechanized underground and open pit mines, as well as smelters. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: